• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基因工程间充质干细胞通过微泡中转录 miR-221 部分保护心肌细胞。

Cardiomyocyte protection by GATA-4 gene engineered mesenchymal stem cells is partially mediated by translocation of miR-221 in microvesicles.

机构信息

Department of Pathology and Laboratory Medicine, University of Cincinnati Medical Center, Cincinnati, Ohio, United States of America.

出版信息

PLoS One. 2013 Aug 28;8(8):e73304. doi: 10.1371/journal.pone.0073304. eCollection 2013.

DOI:10.1371/journal.pone.0073304
PMID:24015301
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3756018/
Abstract

INTRODUCTION

microRNAs (miRs), a novel class of small non-coding RNAs, are involved in cell proliferation, differentiation, development, and death. In this study, we found that miR-221 translocation by microvesicles (MVs) plays an important role in cardioprotection mediated by GATA-4 overexpressed mesenchymal stem cells (MSC).

METHODS AND RESULTS

Adult rat bone marrow MSC and neonatal rat ventricle cardiomyocytes (CM) were harvested as primary cultures. MSC were transduced with GATA-4 (MSC(GATA-4)) using the murine stem cell virus (pMSCV) retroviral expression system. Empty vector transfection was used as a control (MSC(Null)). The expression of miRs was assessed by real-time PCR and localized using in situ hybridization (ISH). MVs collected from MSC cultures were characterized by expression of CD9, CD63, and HSP70, and photographed with electron microscopy. Cardioprotection during hypoxia afforded by conditioned medium (CdM) from MSC cultures was evaluated by lactate dehydrogenase (LDH) release, MTS uptake by CM, and caspase 3/7 activity. Expression of miR-221/222 was significantly higher in MSC than in CM and miR-221 was upregulated in MSC(GATA-4). MSC overexpression of miR-221 significantly enhanced cardioprotection by reducing the expression of p53 upregulated modulator of apoptosis (PUMA). Moreover, expression of PUMA was significantly decreased in CM co-cultured with MSC. MVs derived from MSC expressed high levels of miR-221, and were internalized quickly by CM as documented in images obtained from a Time-Lapse Imaging System.

CONCLUSIONS

Our results demonstrate that cardioprotection by MSC(GATA-4) may be regulated in part by a transfer of anti-apoptotic miRs contained within MVs.

摘要

简介

微小 RNA(miRs)是一类新型的小非编码 RNA,参与细胞增殖、分化、发育和死亡。在本研究中,我们发现通过微泡(MVs)转移的 miR-221 在 GATA-4 过表达间充质干细胞(MSC)介导的心脏保护中发挥重要作用。

方法和结果

从成年大鼠骨髓 MSC 和新生大鼠心室心肌细胞(CM)中获得原代培养物。使用鼠干细胞病毒(pMSCV)逆转录病毒表达系统将 GATA-4 转导至 MSC(MSC(GATA-4))。空载体转染用作对照(MSC(Null))。通过实时 PCR 评估 miR 的表达,并通过原位杂交(ISH)定位。通过 CD9、CD63 和 HSP70 的表达来鉴定 MSC 培养物中收集的 MV,并通过电子显微镜拍摄照片。通过 CM 的乳酸脱氢酶(LDH)释放、MTS 摄取和 caspase 3/7 活性评估 MSC 培养物条件培养基(CdM)提供的缺氧期间的心脏保护作用。miR-221/222 在 MSC 中的表达明显高于 CM,并且 miR-221 在 MSC(GATA-4)中上调。MSC 过表达 miR-221 通过降低促凋亡 p53 上调调节剂(PUMA)的表达显著增强心脏保护作用。此外,与 MSC 共培养的 CM 中 PUMA 的表达明显降低。从 MSC 衍生的 MV 表达高水平的 miR-221,并在 Time-Lapse Imaging System 获得的图像中记录到 CM 快速内化。

结论

我们的结果表明,MSC(GATA-4)的心脏保护作用可能部分受 MV 中包含的抗凋亡 miR 的转移调节。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38da/3756018/14765f6f26aa/pone.0073304.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38da/3756018/1a49fdcd1c7a/pone.0073304.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38da/3756018/5ba4aad3d476/pone.0073304.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38da/3756018/e8ccf4f2c937/pone.0073304.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38da/3756018/a3bbd325c3d6/pone.0073304.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38da/3756018/4edcda1d2ed6/pone.0073304.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38da/3756018/a88159fb3bb1/pone.0073304.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38da/3756018/499e2637e959/pone.0073304.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38da/3756018/14765f6f26aa/pone.0073304.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38da/3756018/1a49fdcd1c7a/pone.0073304.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38da/3756018/5ba4aad3d476/pone.0073304.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38da/3756018/e8ccf4f2c937/pone.0073304.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38da/3756018/a3bbd325c3d6/pone.0073304.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38da/3756018/4edcda1d2ed6/pone.0073304.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38da/3756018/a88159fb3bb1/pone.0073304.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38da/3756018/499e2637e959/pone.0073304.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38da/3756018/14765f6f26aa/pone.0073304.g008.jpg

相似文献

1
Cardiomyocyte protection by GATA-4 gene engineered mesenchymal stem cells is partially mediated by translocation of miR-221 in microvesicles.基因工程间充质干细胞通过微泡中转录 miR-221 部分保护心肌细胞。
PLoS One. 2013 Aug 28;8(8):e73304. doi: 10.1371/journal.pone.0073304. eCollection 2013.
2
Enhanced mesenchymal stem cell survival induced by GATA-4 overexpression is partially mediated by regulation of the miR-15 family.过表达 GATA-4 诱导间充质干细胞存活增强,部分通过 miR-15 家族的调控来实现。
Int J Biochem Cell Biol. 2013 Dec;45(12):2724-35. doi: 10.1016/j.biocel.2013.09.007. Epub 2013 Sep 23.
3
GATA-4 protects against hypoxia-induced cardiomyocyte injury: effects on mitochondrial membrane potential.GATA-4可保护心肌细胞免受缺氧诱导的损伤:对线粒体膜电位的影响。
Can J Physiol Pharmacol. 2014 Aug;92(8):669-78. doi: 10.1139/cjpp-2014-0009. Epub 2014 Jun 11.
4
GATA-4 promotes myocardial transdifferentiation of mesenchymal stromal cells via up-regulating IGFBP-4.GATA-4 通过上调 IGFBP-4 促进间充质基质细胞的心肌转分化。
Cytotherapy. 2011 Oct;13(9):1057-65. doi: 10.3109/14653249.2011.597380. Epub 2011 Aug 17.
5
Exosomes secreted from GATA-4 overexpressing mesenchymal stem cells serve as a reservoir of anti-apoptotic microRNAs for cardioprotection.过表达GATA-4的间充质干细胞分泌的外泌体作为抗凋亡微小RNA的储存库发挥心脏保护作用。
Int J Cardiol. 2015 Mar 1;182:349-60. doi: 10.1016/j.ijcard.2014.12.043. Epub 2014 Dec 23.
6
Paracrine factors released by GATA-4 overexpressed mesenchymal stem cells increase angiogenesis and cell survival.过表达 GATA-4 的间充质干细胞释放的旁分泌因子可增加血管生成和细胞存活。
Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1772-81. doi: 10.1152/ajpheart.00557.2010. Epub 2010 Sep 24.
7
Transduction of Wnt11 promotes mesenchymal stem cell transdifferentiation into cardiac phenotypes.Wnt11 的转导促进间充质干细胞向心脏表型的转分化。
Stem Cells Dev. 2011 Oct;20(10):1771-8. doi: 10.1089/scd.2010.0380. Epub 2011 Feb 26.
8
Clusterin/Akt Up-Regulation Is Critical for GATA-4 Mediated Cytoprotection of Mesenchymal Stem Cells against Ischemia Injury.簇集素/Akt上调对GATA-4介导的间充质干细胞抗缺血损伤细胞保护作用至关重要。
PLoS One. 2016 Mar 10;11(3):e0151542. doi: 10.1371/journal.pone.0151542. eCollection 2016.
9
GATA-4-expressing mouse bone marrow mesenchymal stem cells improve cardiac function after myocardial infarction via secreted exosomes.GATA-4 表达的鼠骨髓间充质干细胞通过分泌的外泌体改善心肌梗死后的心功能。
Sci Rep. 2018 Jun 13;8(1):9047. doi: 10.1038/s41598-018-27435-9.
10
Mesenchymal stem cell-derived exosomes ameliorate cardiomyocyte apoptosis in hypoxic conditions through microRNA144 by targeting the PTEN/AKT pathway.间充质干细胞衍生的外泌体通过 microRNA144 靶向 PTEN/AKT 通路减轻低氧条件下心肌细胞的凋亡。
Stem Cell Res Ther. 2020 Jan 23;11(1):36. doi: 10.1186/s13287-020-1563-8.

引用本文的文献

1
Small extracellular vesicles derived from miRNA-486 overexpressed dental pulp stem cells mitigate high altitude pulmonary edema through PTEN/PI3K/AKT/eNOS pathway.源自miRNA-486过表达牙髓干细胞的小细胞外囊泡通过PTEN/PI3K/AKT/eNOS途径减轻高原肺水肿。
Heliyon. 2025 Jan 14;11(2):e41960. doi: 10.1016/j.heliyon.2025.e41960. eCollection 2025 Jan 30.
2
Hydrogel-integrated exosome mimetics derived from osteogenically induced mesenchymal stem cells in spheroid culture enhance bone regeneration.源自球状体培养中经成骨诱导的间充质干细胞的水凝胶整合外泌体模拟物可增强骨再生。
Biomaterials. 2025 Jun;317:123088. doi: 10.1016/j.biomaterials.2025.123088. Epub 2025 Jan 3.
3

本文引用的文献

1
Role of stem-cell-derived microvesicles in the paracrine action of stem cells.干细胞衍生的微囊泡在干细胞旁分泌作用中的作用。
Biochem Soc Trans. 2013 Feb 1;41(1):283-7. doi: 10.1042/BST20120192.
2
PUMA binding induces partial unfolding within BCL-xL to disrupt p53 binding and promote apoptosis.PUMA 结合诱导 BCL-xL 发生部分展开,从而破坏 p53 结合并促进细胞凋亡。
Nat Chem Biol. 2013 Mar;9(3):163-8. doi: 10.1038/nchembio.1166. Epub 2013 Jan 20.
3
Cardiac progenitor-derived exosomes protect ischemic myocardium from acute ischemia/reperfusion injury.
Enhancing cardiac regeneration: direct reprogramming of fibroblasts into myocardial-like cells using extracellular vesicles secreted by cardiomyocytes.
增强心脏再生:利用心肌细胞分泌的细胞外囊泡将成纤维细胞直接重编程为心肌样细胞。
Mol Cell Biochem. 2025 May;480(5):3185-3200. doi: 10.1007/s11010-024-05184-w. Epub 2024 Dec 24.
4
Mesenchymal Stem Cells-Derived Small Extracellular Vesicles and Their Validation as a Promising Treatment for Chondrosarcoma in a 3D Model in Vitro.间充质干细胞衍生的小细胞外囊泡及其在体外3D模型中作为软骨肉瘤有前景治疗方法的验证
Biotechnol Bioeng. 2025 Mar;122(3):667-676. doi: 10.1002/bit.28909. Epub 2024 Dec 17.
5
Therapeutic combinations of exosomes alongside cancer stem cells (CSCs) and of CSC-derived exosomes (CSCEXs) in cancer therapy.外泌体与癌症干细胞(CSCs)的治疗组合以及癌症治疗中癌症干细胞衍生外泌体(CSCEXs)的治疗组合。
Cancer Cell Int. 2024 Oct 5;24(1):334. doi: 10.1186/s12935-024-03514-y.
6
Mesenchymal stem cells as future treatment for cardiovascular regeneration and its challenges.间充质干细胞作为心血管再生的未来治疗方法及其面临的挑战。
Ann Transl Med. 2024 Aug 1;12(4):73. doi: 10.21037/atm-23-1936. Epub 2023 Dec 29.
7
Mesenchymal Stem Cell-Derived Exosomes in Cardioprotection: A Novel Application to Prevent Myocardial Injury.间充质干细胞衍生外泌体在心脏保护中的作用:预防心肌损伤的新应用
Rev Cardiovasc Med. 2022 Sep 13;23(9):310. doi: 10.31083/j.rcm2309310. eCollection 2022 Sep.
8
Research hotspots and emerging trends of mesenchymal stem cells in cardiovascular diseases: a bibliometric-based visual analysis.间充质干细胞在心血管疾病中的研究热点与新趋势:基于文献计量学的可视化分析
Front Cardiovasc Med. 2024 May 30;11:1394453. doi: 10.3389/fcvm.2024.1394453. eCollection 2024.
9
Therapeutic Effects of Mesenchymal Stem Cell-Derived Extracellular Vesicles in sepsis: a Systematic Review and Meta-Analysis of Preclinical Studies.间充质干细胞衍生的细胞外囊泡在脓毒症中的治疗作用:一项临床前研究的系统评价和荟萃分析
Stem Cell Rev Rep. 2024 Aug;20(6):1480-1500. doi: 10.1007/s12015-024-10741-3. Epub 2024 May 30.
10
Exosomal mediators in sepsis and inflammatory organ injury: unraveling the role of exosomes in intercellular crosstalk and organ dysfunction.脓毒症和炎症性器官损伤中的外泌体介质:揭示外泌体在细胞间通讯和器官功能障碍中的作用
Mil Med Res. 2024 Apr 22;11(1):24. doi: 10.1186/s40779-024-00527-6.
心肌祖细胞衍生的外泌体可保护缺血心肌免受急性缺血/再灌注损伤。
Biochem Biophys Res Commun. 2013 Feb 15;431(3):566-71. doi: 10.1016/j.bbrc.2013.01.015. Epub 2013 Jan 11.
4
Therapeutic potential of mesenchymal stem cell-derived microvesicles.间充质干细胞来源的微囊泡的治疗潜力。
Nephrol Dial Transplant. 2012 Aug;27(8):3037-42. doi: 10.1093/ndt/gfs168.
5
Mesenchymal stem cells secrete multiple cytokines that promote angiogenesis and have contrasting effects on chemotaxis and apoptosis.间充质干细胞分泌多种细胞因子,促进血管生成,并对趋化作用和细胞凋亡有相反的影响。
PLoS One. 2012;7(4):e35685. doi: 10.1371/journal.pone.0035685. Epub 2012 Apr 25.
6
Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease.间质干细胞外泌体:一种基于干细胞的新型心血管疾病治疗方法。
Regen Med. 2011 Jul;6(4):481-92. doi: 10.2217/rme.11.35.
7
Intracoronary mesenchymal stem cells promote postischemic myocardial functional recovery, decrease inflammation, and reduce apoptosis via a signal transducer and activator of transcription 3 mechanism.冠状动脉内间充质干细胞通过信号转导和转录激活因子 3 机制促进缺血后心肌功能恢复、减少炎症和降低细胞凋亡。
J Am Coll Surg. 2011 Aug;213(2):253-60. doi: 10.1016/j.jamcollsurg.2011.04.005. Epub 2011 May 5.
8
MicroRNA-221 regulates FAS-induced fulminant liver failure.MicroRNA-221 调控 FAS 诱导的暴发性肝衰竭。
Hepatology. 2011 May;53(5):1651-61. doi: 10.1002/hep.24243. Epub 2011 Mar 11.
9
Stem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challenges.基于干细胞和祖细胞的治疗缺血性心脏病:前景、不确定性和挑战。
Eur Heart J. 2011 May;32(10):1197-206. doi: 10.1093/eurheartj/ehr018. Epub 2011 Feb 28.
10
Mesenchymal stem cell conditioned media attenuates in vitro and ex vivo myocardial reperfusion injury.间充质干细胞条件培养基可减轻体外和体内心肌再灌注损伤。
J Heart Lung Transplant. 2011 Jan;30(1):95-102. doi: 10.1016/j.healun.2010.08.023. Epub 2010 Oct 27.